Navigation Links
Nearly 25% of Women With Early Ovarian Cancer Not Given Recommended Biopsies
Date:2/10/2011

THURSDAY, Feb. 10 (HealthDay News) -- More than one-quarter of women with apparent early-stage ovarian cancer don't receive recommended lymph node biopsies to check for cancer spread, which nearly doubles these patients' risk of death, say U.S. researchers.

The team at the University of California Davis Cancer Center and California Cancer Registry analyzed the medical records and cancer registry data of 721 presumed early-stage ovarian cancer patients in California and New York and found that only 72 percent had lymph nodes from the pelvis and abdomen tested for signs of cancer spread.

The five-year survival rate was 84 percent for patients who had lymph node biopsies and 69 percent for those who did not have the biopsies.

The study also found that gynecologic oncologists were nearly 6.5 times more likely to perform lymph node biopsies than other surgical specialists, and nearly four times more likely to perform all recommended staging biopsies.

It's not clear why some surgeons do not remove lymph nodes during surgery for early-stage ovarian cancer, said senior author Dr. Gary Leiserowitz, chief of gynecologic oncology at the UC Davis Cancer Center, in a university news release. It may be that they don't believe the patient would benefit either because they're older or have other serious health problems, or both.

But unless a patient is clearly medically unsuited for the lifesaving biopsies, they should be done, study authors added.

The study appears online and in the April print issue of the journal Gynecological Oncology.

More information

The U.S. National Cancer Institute has more about ovarian cancer.

-- Robert Preidt

SOURCE: University of California, Davis, news release, Feb. 2, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Researchers predict nearly 1.3 million cancer deaths in Europe in 2011
2. Obesity Has Nearly Doubled Worldwide Since 1980: Report
3. Nearly Half of Americans Still Suspect Vaccine-Autism Link
4. Personalized vaccine for lymphoma patients extends disease-free survival by nearly 2 years
5. National Cancer Institute awards nearly $4 million to University of New Mexico Cancer Center
6. Healthy Living Can Prevent Nearly 25% of Colorectal Cancers
7. Nearly 1 in 5 W.Va. 5th Graders May Have High Blood Pressure
8. Scientists receive nearly $11 million to develop radiation countermeasures
9. Eye Disease Affects Nearly One in Three Diabetics
10. Nearly 1 in 5 Californians report need for mental health services, study finds
11. Susan G. Komen awards Case Western Reserve nearly $500,000 to study breast cancer in older women
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nearly 25% of Women With Early Ovarian Cancer Not Given Recommended Biopsies
(Date:6/27/2016)... ... June 27, 2016 , ... ePAY ... partnership with Connance, a healthcare industry leader providing predictive analytics to optimize ... combine to provide health systems, hospitals and ambulatory surgical centers with dramatic ...
(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: